• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

World Market for Prescription Dermatological Drugs, Forecasts to 2020, 9th Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)

$1,995.00 – $3,995.00

Clear
SKU: KLI5670561 Categories: Pharmaceuticals Market Research, Prescription Drugs Market Reports Pages: 446
  • Description
  • Table of Contents
  • Latest reports

Description

World Market for Prescription Dermatological Drugs, 9th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)

The worldwide market for prescription dermatological drugs encompasses a wide variety of products that treat disorders of the skin as well as the effects of aging. It’s a very dynamic time for the prescription dermatological drug industry. Consolidation, economic times, new technologies and genetic discoveries are among the trends that the industry is seeing.

Dermatological drugs are currently experiencing a busy and interesting period and, as a result, the range of therapeutic options available to physicians has expanded.This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the ninth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors that may help to shape the market for treatments in the future.

The driving forces for the dermatology drug market include growth and aging of the worldwide population, new products and technologies, and focus on lifestyle treatments that improve the effects of aging and damage to the skin. Within the pharmaceutical industry as a whole, financial depression, consolidation and economic downturns have influenced the market.

The worldwide market for prescription dermatology drugs includes products in the following categories:

  • Prescription Acne and Rosacea Drugs
  • Prescription Antiaging and Photodamage Drugs
  • Prescription Dermatitis and Seborrhea Drugs
  • Prescription Fungal Infection Drugs
  • Prescription Hair Loss and Hair Removal Drugs
  • Prescription Hyperpigmentation/Melasma Drugs
  • Prescription Psoriasis Drugs
  • Prescription Skin Cancer Drugs
  • Other Prescription Skin Disorder Drugs

This report details the various categories of prescription dermatological drugs, describes the worldwide market for prescription dermatological drugs, and identifies major market factors that may help to shape the worldwide market for prescription dermatological drugs in the future.

The pharmaceutical industry is facing a tougher environment in general, due to harder regulations for gaining approvals for mainstream products, economic issues, and a dwindling pipeline of new products. Reliance on blockbuster drugs is all but over, causing a shift of focus for many drug research and development entities. By focusing on cosmetic medications, many manufacturers are realizing less scrutiny from the FDA and a growing need in the niche markets such as dermatology. This transition will play a role in the future development of the dermatological industry over the forecast period. The worldwide pharmaceutical sector has little choice but to continue expanding through mergers and acquisitions for some time to come. The sector is ripe for the picking, too, with the financial crisis having created an impressive buyer’s market for larger companies, as smaller firms struggle to extend financing. True globalization of pharmaceuticals has arrived. Most of the growth in the next few years will be outside the US, Europe and Japan. It’s a very dynamic time for the industry focusing on a worldwide market.

The information and analysis presented in this report are based on extensive interviews with senior management of top companies in the dermatology market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 30 industry executives and product managers to validate and obtain expert opinion on current and future trends in the dermatological market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.

All market data pertains to the worldwide market at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year for data was 2015. Historical data are provided for each of the years 2013 to 2014, and forecast data are provided for each of the years 2015 through 2020. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2015 base year.

The following companies are profiled in this report:

Allergan Inc.
Allergan Inamed Corporation
Barrier Therapeutics, Inc
Bayer AG
PharmaDerm Pharmaceuticals, Inc
Bristol-Myers Squibb
Collagenex (now Galderma) Pharmaceuticals
Galderma S.A.
Genentech, Inc.
GlaxoSmithKline Plc
Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
Medicis Pharmaceutical Corporation
Merck & Company, Inc.
Mylan Pharmaceuticals, Inc,
Novartis Pharmaceuticals Corporation
Nycomed Inc.
Pfizer, Inc.
Q-Med AB
Roche Group (F. Hoffmann-La Roche Ltd.)
Schering (now Merck)-Plough Corporation
Sinclair Pharma Plc.
SkinMedica
Stiefel Laboratories, Inc.
Valeant Pharmaceuticals, Inc.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Introduction

Scope and Methodology

Size and Growth of the Market

Issues and Trends Affecting Market

Competitor Analysis

CHAPTER TWO: INTRODUCTION

Structure and Function of the Skin

Epidermis

Dermis

Subcutaneous Tissue

Epidermal Appendages

Functions of the Skin

Effects of Aging on the Skin

Dermatological Conditions and Treatment

Pharmacokinetics

Drug Absorption

Distribution

Bioavailability

Drug Delivery Methods

Demographics of Skin Disorders, Incidence, and Prevalence

CHAPTER THREE: ISSUES AND TRENDS

Patient Compliance

Cosmetic Dermatologists

Sunscreen Use

Melanoma Survival Rates Falter

Indoor Tanning Issue

Phosphatidylglycerol and Psoriasis

New Filler Options

Consumer Confusion

Genetic Link to Psoriasis

Biologic Dermatology

Rx-to-OTC Switches

Cosmeceuticals

Antioxidants

Polypeptides

Teledermatology

Reimbursement Issues

Market Shift Towards less invasive Procedures

Medi-Spas

Combination therapies Thrive

Competitive, Economic, Social Forces Driving Market Demand

Society’s Obsession with Physical Appearance

Regulatory Influences: US & International

International Authorities

U.S. FDA & Other Regulatory Agencies

Effects of Health Insurance Programs & Treatment Costs

Competitive Influences—Impact on Market & Treatment Modalities

Facial Skin–Bio-Physiology

The “Gray Areas” of Medicine

Laser Therapy

Narrowband Ultraviolet B

Photodynamic Therapy

PYCR1 Gene

Changes in Credit Card Terms

Patient Protection and Affordable Care Act

Thermage

BRAF Gene

New Oral Medications and Research for Acne

Synthetic Lipids for Skin Healing

Importance of Drug Delivery

Industry Consolidation

CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS .69

Description of Disorders

Description of Products

Benzoyl Peroxide

Description of Products

Current Suppliers

Retinoids

Topical Formulations

All-trans Retinoic Acid (Tretinoin)

Adapalene

Tazarotene

Systemic Formulations

Isotretinoin

Current Suppliers

Antibiotics

Description of Products

Azelaic Acid

Clindamycin

Erythromycin

Metronidazole

Sodium Sulfacetamide

Others

Current Suppliers

Oral Contraceptives

Research and Development

Market Size and Growth

Worldwide Market

Markets by Geographical Region

United States

Europe

Japan

Rest of World

The Future of the Market

Competitive Analysis

CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS

Overview

Description of Products

Keratolytics

Moisturizers

Retinoids

Sunscreens

Botox and Fillers

Research and Development

Market Size and Growth

Worldwide Market

Markets by Geographical Region

United States

Europe

Japan

Rest of World

The Future of the Market

Competitive Analysis

CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS

Overview

Description of Products

Topical Corticosteroids

Systemic Corticosteroids

Other Products

Research and Development

Market Size and Growth

Worldwide Market by Type

Markets by Geographical Region

United States

Europe

Japan

Rest of World

Future of the Market

Competitive Analysis

CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS

Overview

Description of Products

Systemic Formulations

Terbinafine

Itraconazole

Fluconazole

Griseofulvin

Ketoconazole

Echinocandin

Current Suppliers

Topical Formulations

Polyenes

Azoles

Miconazole

Clotrimazole

Ketoconazole

Oxiconazole

Econazole

Sulconazole

Allylamines and Benzylamines

Naftifine

Terbinafine

Butenafine

Other Topical Formulations

Novel Products

Current Suppliers

Research and Development

Market Size and Growth

Worldwide Market by Type

Markets by Geographical Region

United States

Europe

Japan

Rest of World

Future of the Market

Competitive Analysis

CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS

Overview

Description of Products

Antiandrogens

Androgen Inhibitors

Other Treatments

Research and Development

Market Size and Growth

Worldwide Market by Type

Markets by Geographical Region

United States

Europe

Japan

Rest of World

Future of the Market

Competitive Analysis

CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION/MELASMA AND DEPIGMENTING DRUGS

Overview

Description of Products

Market Size and Growth

Worldwide Market

Markets by Geographical Region

United States

Europe

Japan

Rest of World

Research and Development

The Future of the Market

Competitive Analysis

CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS

Overview

Description of Products

Selected Topical Psoriasis Products

Anthralin

Coal Tar

Methoxsalen

Second-generation Retinoids

Tazarotene

Topical Vitamin D

Vitamin D Analogs

Vanos

Vectical Ointment

Selected Systemic Psoriasis Preparations

Betamethasone

Cortisone Acetate

Cyclosporine

Hydrocortisone

Methotrexate

Olopatadine Hydrochloride

Tacrolimus

Light Therapy

Biologics

Novel Products

Research and Development

Market Size and Growth

Worldwide Market by Type

Markets by Geographical Region

United States

Europe

Japan

Rest of World

Future of the Market

Competitive Analysis

CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS

Overview

Nonmelanoma Skin Cancers

Actinic Keratoses

Basal Cell Carcinoma

Squamous Cell Carcinoma

Cutaneous T-cell Lymphoma

Dysplastic Nevus Syndrome

Malignant Melanoma

Description of Products

5-Fluorouracil

Mechlorethamine/Nitrogen Mustard

Carmustine/BCNU (Topical)

Vinblastine (Intralesional) and Others

Research and Development

Market Size and Growth

Worldwide Market

Markets by Geographical Region

United States

Europe

Japan

Rest of World

The Future of the Market

Competitive Analysis

CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS

Overview

Antivirals

Antiparasitics

Description of Products

Antivirals

Antiviral Drugs

Immunoenhancing Drugs

Current Suppliers

Antiparasitic Agents

Current Suppliers

Other Skin Related Products

Research and Development

Market Size and Growth

Worldwide Market

Markets by Geographical Region

United States

Europe

Japan

Rest of World

The Future of the Market

Competitive Analysis

CHAPTER THIRTEEN: WORLD MARKET SUMMARY

Overview

Total Market Size and Forecast

Market Analysis by Country

United States

Europe

Japan

Rest of World

Market and Competitive Analysis

CHAPTER FOURTEEN: CORPORATE PROFILES

AbbVie, Inc.

Allergan

Amgen, Inc.

Anacor Pharmaceuticals, Inc.

Astellas Pharma, Inc.

Bayer AG

Bristol-Myers Squibb

Galderma S.A.

Genentech, Inc.

GlaxoSmithKline Plc

Johnson & Johnson

Merck & Company, Inc.

Mylan N.V

Novartis Pharmaceuticals Corporation

Pfizer, Inc.

PharmaDerm

Stiefel

Sinclair IS Pharma Plc.

Stratus Pharmaceuticals, Inc.

Valeant Pharmaceuticals International

APPENDIX

LIST OF COMPANIES

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1

The Worldwide Market for Prescription Dermatological Drugs 2013, 2015, and

2020

Figure 1-1

The Worldwide Market for Prescription Dermatological Drugs 2013, 2015, and

2020

CHAPTER TWO: INTRODUCTION

Table 2-1

Common Bases for Topical Dermatological Medications

Table 2-2

Worldwide Incidence and Prevalence of Selected Dermatologic Conditions

CHAPTER THREE: ISSUES AND TRENDS

Table 3-1

Selected Dermatological Rx-to-OTC Switches

Table 3-2

Cy 2015 Relative Value Units (Rvus) and Related Information Used In Determining Final Medicare Payments

CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS

Table 4-1

Common Benzoyl Peroxide Formulations

Table 4-2

Common Retinoid Formulations

Table 4-3

Common Topical Antibiotic Formulations

Table 4-3 (continued)

Common Topical Antibiotic Formulations

Table 4-3 (continued)

Common Topical Antibiotic Formulations

Table 4-4

Common Oral Contraceptive Formulations

Table 4-5

Prescription Acne, Actinic Keratosis and Rosacea Formulations in Development

Table 4-6

The Worldwide Market for Prescription Acne and Rosacea Drugs by Type 2013- 2020

Figure 4-1

The Worldwide Market for Prescription Acne and Rosacea Drugs Revenues by Type, 2013-2020

Figure 4-2

The Worldwide Market for Prescription Acne and Rosacea Drugs Share by Type 2015

Figure 4-3

The Worldwide Market for Prescription Acne and Rosacea Drugs Share by Type 2020

Table 4-7

Top Five EU Countries Prescription Psoriasis Markets by Revenues and Percent 2015 (in millions $)

Table 4-8

Top Four Rest of World Countries Prescription Psoriasis Markets by Revenues and Percent 2015 (in millions $)

Table 4-9

The Worldwide Market for Prescription Antiacne and Rosacea Drugs by Geographical Region 2013-2020

Figure 4-4

The Worldwide Market for Prescription Antiacne and Rosacea Drugs Revenues by Geographical Region 2013-2020

Figure 4-5

The Worldwide Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2015

Figure 4-6

The Worldwide Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2020

Table 4-10

Worldwide Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier 2015

Figure 4-7

Worldwide Market for Acne and Rosacea Drugs Market Share by Leading Supplier 2015

CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS

Table 5-1

Common Prescription Keratolytic Formulations

Table 5-2

Occlusive Moisturizers—Categories of Ingredients

Table 5-3

Common Prescription Moisturizers

Table 5-4

Common Prescription Retinoids for Antiaging and Photodamage

Table 5-5

Common Prescription Sunscreens

Table 5-6

Other Prescription Antiaging and Photodamage Products

Table 5-7

Prescription Antiaging and Photodamage Formulations in Development

Table 5-8

The Worldwide Market Antiaging and Photodamage Drugs by Type 2013-2020

Figure 5-1

The Worldwide Market for Antiaging and Photodamage Drugs Revenues by

Type 2013-2020

Figure 5-2

The Worldwide Market for Antiaging and Photodamage Drugs Share by Type 2015

Figure 5-3

The Worldwide Market for Antiaging and Photodamage Drugs Share by Type 2020

Table 5-9

Top Five EU Countries Prescription Antiaging and Photodamage Drug Markets by Revenues and Percent 2015

Table 5-10

Top Four Rest of World Countries Prescription Antiaging and Photodamage Drug Markets by Revenues and Percent 2015

Table 5-11

The Worldwide Market for Prescription Antiaging and Photodamage Drugs by Geographical Region 2013-2020

Figure 5-4

The Worldwide Market for Prescription Antiaging and Photodamage Drugs, Revenues by Geographical Region 2013-2020

Figure 5-5

The Worldwide Market for Antiaging and Photodamage Drugs Share by Geographical Region 2015

Figure 5-6

The Worldwide Market for Antiaging and Photodamage Drugs Share by Geographical Region 2020

Table 5-12

Worldwide Market for Prescription Antiaging and Photodamage Drugs Revenues and Market Share by Supplier 2015

Figure 5-7

Worldwide Market for Prescription Antiaging and Photodamage Drugs, Market Share by Leading Supplier 2015

CHAPTER SIX:

PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS

Table 6-1

Common Prescription Topical Corticosteroid Preparations

Table 6-1 (continued)

Common Prescription Topical Corticosteroid Preparations

Table 6-2

Common Prescription Systemic Corticosteroids

Table 6-3

Prescription Other Dermatitis Formulations

Table 6-4

Prescription Dermatitis Formulations in Development

Table 6-5

The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs by Type 2013-2020

Figure 6-1

The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Type 2013-2020

Figure 6-2

The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2015

Figure 6-3

The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2020

Table 6-6

Top Five EU Countries Prescription Dermatitis and Seborrhea Drug Markets by Revenues and Percent 2015 (in millions $)

Table 6-7

Top Four Rest of World Countries Prescription Dermatitis and Seborrhea Drug Markets by Revenues and Percent 2015 (in millions $)

Table 6-8

The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs by

Geographical Region 2013-2020

Figure 6-4

The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Geographical Region 2013-2020

Figure 6-5

The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2015

Figure 6-6

The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2020

Table 6-9

Worldwide Market for Prescription Dermatitis and Seborrhea Drugs, Revenues and Market Share by Supplier 2015

Figure 6-7

Worldwide Market for Prescription Dermatitis and Seborrhea Drugs Market

Share by Leading Supplier 2015

CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS

Table 7-1

Common Prescription Systemic Antifungal Dermatological Formulations

Table 7-2

Common Prescription Topical Antifungal Dermatological Drugs

Table 7-3

Prescription Antifungal Dermatological Drugs in Development

Table 7-4

The Worldwide Market for Prescription Antifungal Dermatological Drugs by Type 2013-2020

Figure 7-1

The Worldwide Market for Prescription Antifungal Dermatological Drugs Revenues by Type 2013-2020

Figure 7-2

The Worldwide Market for Prescription Antifungal Dermatological Drugs, Share by Type 2015

Figure 7-3

The Worldwide Market for Prescription Antifungal Dermatological Drugs, Share by Type 2020

Table 7-5

Top Five EU Countries Prescription Dermatological Antifungal Drug Markets by Revenues and Percent 2015

Table 7-6

Top Four Rest of World Countries Prescription Dermatological Antifungal Drug Markets by Revenues and Percent 2015

Table 7-7

The Worldwide Market for Prescription Antifungal Dermatological Drugs by Geographical Region 2013-2020

Figure 7-4

The Worldwide Market for Prescription Antifungal Dermatological Drugs Revenues by Geographical Region 2013-2020

Figure 7-5

The Worldwide Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2015

Figure 7-6

The Worldwide Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2020

Table 7-8

Worldwide Market for Prescription Antifungal Dermatological Drugs Revenues and Market Share by Supplier 2015

Figure 7-7

Worldwide Market for Prescription Antifungal Dermatological Drugs Market Share by Leading Supplier 2015

CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS

Table 8-1

Common Prescription Hair Loss or Hair Removal Formulations

Table 8-2

Prescription Hair Loss or Hair Removal Formulations in Development

Table 8-3

The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs by Type 2013-2020

Figure 8-1

The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs Revenues by Type 2013-2020

Figure 8-2

The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs, Share by Type 2015

Figure 8-3

The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs, Share by Type 2020

Table 8-4

Top Five EU Countries Prescription Dermatological Hair Loss and Hair Removal Drug Markets by Revenues and Percent 2015

Table 8-5

Top Four Rest of World Countries Prescription Dermatological Hair Loss and Hair Removal Drug Markets by Revenues and Percent 2015

Table 8-6

The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs, Revenues by Geographical Region 2013-2020

Figure 8-4

The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs, Revenues by Geographical Region 2013-2020

Figure 8-5

The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs, Share by Geographical Region 2015

Figure 8-6

The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs Share by Geographical Region 2020

Table 8-7

Worldwide Market for Prescription Hair Loss and Hair Removal Drugs Revenues and Market Share by Supplier 2015

Figure 8-7

Worldwide Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Leading Supplier 2015

CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION/MELASMA AND DEPIGMENTING DRUGS

Table 9-1

Common Prescription Hyperpigmentation/Melasma Formulations

Table 9-2

Common Prescription Depigmenting Agents

Table 9-3

The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs by Type 2013-2020

Figure 9-1

The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs Revenues by Type 2013-2020

Figure 9-2

The Worldwide Market for Prescription Hyperpigmentation/ Melasma and Depigmenting Drugs, Share by Type 2015

Figure 9-3

The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs Share by Type 2020

Table 9-4

The Worldwide Market for Prescription Hyperpigmentation/Melasma Drugs by Geographical Region 2013-2020

Figure 9-4

The Worldwide Market for Prescription Hyperpigmentation/Melasma Drugs Revenues by Geographical Region 2013-2020

Figure 9-5

The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs, Share by Geographical Region 2015

Figure 9-6

The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs, Share by Geographical Region 2020

CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS

Table 10-1

Selected Common Prescription Psoriasis Preparations

Selected Common Prescription Psoriasis Preparations

Table 10-2

Common Prescription Biologics for Psoriasis Treatment

Table 10-3

Prescription Psoriasis Preparations in Development

Table 10-3 (cont)

Prescription Psoriasis Preparations in Development

Table 10-4

The Worldwide Market for Prescription Psoriasis Drugs by Type 2013-2020 273

Figure 10-1

The Worldwide Market for Prescription Psoriasis Drugs Revenues by Type 2013-2020

Figure 10-2

The Worldwide Market for Prescription Psoriasis Drugs Share by Type 2015 275

Figure 10-3

The Worldwide Market for Prescription Psoriasis Drugs Share by Type 2020 276

Table 10-5

Top Five EU Countries Prescription Psoriasis Markets by Revenues and Percent 2015

Table 10-6

Top Four Rest of World Countries Prescription Psoriasis Markets by Revenues and Percent 2015

Table 10-7

The Worldwide Market for Prescription Psoriasis Drugs by Geographical Region 2013-2020

Figure 10-4

The Worldwide Market for Prescription Psoriasis Drugs Revenues by Geographical Region 2013-2020

Figure 10-5

The Worldwide Market for Prescription Psoriasis Drugs Share by Geographical Region 2015

Figure 10-6

The Worldwide Market for Prescription Psoriasis Drugs Share by Geographical Region 2020

Table 10-8

Worldwide Market for Prescription Psoriasis Drugs Revenues and Market Share by Supplier 2015

Figure 10-7

Worldwide Market for Prescription Psoriasis Drugs Market Share by Leading Supplier 2015

CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS

Table 11-1

Malignant Conditions of the Skin

Table 11-2

Common Prescription Topical, Intralesional and Other Skin Cancer Agents . 296

Table 11-3

Prescription Skin Cancer Preparations in Development

Table 11-3 (continued)

Prescription Skin Cancer Preparations in Development

Table 11-4

The Worldwide Market for Skin Cancer Drugs 2013-2020

Figure 11-1

The Worldwide Market for Skin Cancer Drugs 2013-2020

Table 11-5

Top Five EU Countries Prescription Psoriasis Markets by Revenues and Percent 2015

Table 11-6

Top Four Rest of World Countries Prescription Psoriasis Markets by Revenues and Percent 2015

Table 11-7

The Worldwide Market for Prescription Skin Cancer Drugs by Geographical Region 2013-2020

Figure 11-2

The Worldwide Market for Prescription Skin Cancer Drugs Revenues by Geographical Region 2013-2020

Figure 11-3

The Worldwide Market for Prescription Skin Cancer Drugs Share by Geographical Region 2015

Figure 11-4

The Worldwide Market for Prescription Skin Cancer Drugs Share by Geographical Region 2020

Table 11-8

Worldwide Market for Prescription Skin Cancer Drugs Revenues and Market Share by Supplier 2015

Figure 11-5

Worldwide Market for Skin Cancer Drugs Market Share by Leading Supplier 2015

CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS

Table 12-1

Common Prescription Dermatological Systemic and Topical Antiviral

Formulations

Table 12-2

Common Prescription Topical Antiparasitic Formulations

Table 12-3

Common Prescription Other Skin Formulations

Table 12-4

Prescription Miscellaneous Skin Preparations in Development

Table 12-5

The Worldwide Market for Prescription Miscellaneous Skin Disorder Drugs by Type 2013-2020

Figure 12-1

The Worldwide Market for Miscellaneous Skin Disorder Drugs Revenues by Type 2013-2020

Figure 12-2

The Worldwide Market for Miscellaneous Skin Disorder Drugs Share by Type 2015

Figure 12-3

The Worldwide Market for Miscellaneous Skin Disorder Drugs Share by Type 2020

Table 12-6

Top Five EU Countries Prescription Miscellaneous Skin Disorder Drug Markets by Revenues and Percent 2015

Table 12-7

Top Four Rest of World Countries Prescription Miscellaneous Skin Disorder Drug Markets by Revenues and Percent 2015

Table 12-8

The Worldwide Market for Prescription Miscellaneous Skin Disorder Drugs by

Geographical Region 2013-2020

Figure 12-4

The Worldwide Market for Prescription Miscellaneous Drugs Revenues by Geographical Region 2013-2020

Figure 12-5

The Worldwide Market for Prescription Miscellaneous Drugs Share by Geographical Region 2015

Figure 12-6

The Worldwide Market for Prescription Miscellaneous Drugs Share by Geographical Region 2020

CHAPTER THIRTEEN: WORLD MARKET SUMMARY

Table 13-1

The Worldwide Market for Prescription Dermatological Drugs, Revenues by Segment, 2013-2020

Figure 13-1

The Worldwide Market for Prescription Dermatological Drugs Revenues by Dermatological Segment 2013-2020

Figure 13-2

The Worldwide Market for Dermatological Drugs Market Share by Type 2015

Figure 13-3

The Worldwide Market for Dermatological Drugs Market Share by Type 2020

Table 13-2

Worldwide Prescription Dermatological Drug Market Analysis by Region/Country, 2015

Figure 13-4

Worldwide Prescription Dermatological Drug Market Analysis by Region/Country, 2015

Figure 13-5

Worldwide Prescription Dermatological Drug Market Analysis by Region/Country, 2020

Table 13-3

Worldwide Market for Prescription Dermatological Drugs Segments of Major Participation by Manufacturer 2015

Table 13-4

Worldwide Market for Prescription Dermatological Drug Revenues and Market Share by Supplier 2015

LIST OF COMPANIES

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    World Market for Anti-infectives Series: Volumes I – III – Antifungals, Antibacterials and Antivirals, The

    $6,000.00 – $12,000.00
  • Placeholder image

    Rheumatoid Arthritis: The 45 Market in the United States for Drugs and Biologics

    $2,246.00 – $4,492.00
  • Placeholder image

    Outsourcing in Drug Development – The Contract Research Market from Preclinical to Phase III

    $3,500.00 – $7,000.00
  • Placeholder image

    U.S. Market for OTC Diet Aids, The

    $3,000.00 – $6,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Biotechnology Companies in Emerging Markets (China, Singapore, Brazil, South...The Worldwide Market for Bioreactors: Forecasts to 2019
Scroll to top